Aevi Genomic Medicine (GNMX) Short Interest Ratio & Short Volume → Trending Stocks Sent To You In Real Time (From Huge Alerts) (Ad) Free GNMX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Aevi Genomic Medicine Short Interest DataCurrent Short Volume338,700 sharesPrevious Short Volume263,200 sharesChange Vs. Previous Month+28.69%Dollar Volume Sold Short$60,966.00Short Interest Ratio / Days to Cover0.2Last Record DateJanuary 31, 2020Outstanding Shares77,714,000 sharesFloat Size54,380,000 sharesShort Percent of Float0.62%Today's Trading Volume2,945,816 sharesAverage Trading Volume3,164,141 sharesToday's Volume Vs. Average93% Short Selling Aevi Genomic Medicine ? Sign up to receive the latest short interest report for Aevi Genomic Medicine and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGNMX Short Interest Over TimeGNMX Days to Cover Over TimeGNMX Percentage of Float Shorted Over Time Ad MarketBeatYour $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionStart Your Risk-Free Trial Here Aevi Genomic Medicine Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/2020338,700 shares $60,966.00 +28.7%0.6%0.2 $0.18 1/15/2020338,700 shares $60,966.00 +28.7%0.6%0.2 $0.18 12/31/2019263,200 shares $39,480.00 -14.4%0.5%0.2 $0.15 GNMX Short Interest - Frequently Asked Questions What is Aevi Genomic Medicine's current short interest? Short interest is the volume of Aevi Genomic Medicine shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 338,700 shares of GNMX short. 0.62% of Aevi Genomic Medicine's shares are currently sold short. Learn More on Aevi Genomic Medicine's current short interest. What is a good short interest percentage for Aevi Genomic Medicine? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.62% of Aevi Genomic Medicine's floating shares are currently sold short. Is Aevi Genomic Medicine's short interest increasing or decreasing? Aevi Genomic Medicine saw a increase in short interest in January. As of January 31st, there was short interest totaling 338,700 shares, an increase of 28.7% from the previous total of 263,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aevi Genomic Medicine's float size? Aevi Genomic Medicine currently has issued a total of 77,714,000 shares. Some of Aevi Genomic Medicine's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aevi Genomic Medicine currently has a public float of 54,380,000 shares. How does Aevi Genomic Medicine's short interest compare to its competitors? 0.62% of Aevi Genomic Medicine's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Aevi Genomic Medicine: Evaxion Biotech A/S (1.06%), BioCardia, Inc. (6.17%), Acorda Therapeutics, Inc. (0.77%), Organovo Holdings, Inc. (1.35%), Genetic Technologies Limited (0.72%), Coeptis Therapeutics Holdings, Inc. (0.18%), Eiger BioPharmaceuticals, Inc. (2.56%), Creative Medical Technology Holdings, Inc. (3.14%), Senti Biosciences, Inc. (0.83%), Titan Pharmaceuticals, Inc. (2.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Tesla, Inc. ($17.72 billion), Netflix, Inc. ($7.24 billion), Charter Communications, Inc. ($4.67 billion), Microchip Technology Incorporated ($3.34 billion), The Charles Schwab Co. ($2.53 billion), Match Group, Inc. ($2.07 billion), Carvana Co. ($1.86 billion), Omnicom Group Inc. ($1.86 billion), Snap Inc. ($1.75 billion), and Zillow Group, Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Aevi Genomic Medicine stock? Short selling GNMX is an investing strategy that aims to generate trading profit from Aevi Genomic Medicine as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aevi Genomic Medicine? A short squeeze for Aevi Genomic Medicine occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GNMX, which in turn drives the price of the stock up even further. How often is Aevi Genomic Medicine's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNMX, twice per month. The most recent reporting period available is January, 31 2020. More Short Interest Resources from MarketBeat Related Companies: Evaxion Biotech A/S Short Squeeze BioCardia Short Squeeze Acorda Therapeutics Short Squeeze Organovo Short Squeeze Genetic Technologies Short Squeeze Coeptis Therapeutics Short Squeeze Eiger BioPharmaceuticals Short Squeeze Creative Medical Technology Short Squeeze Senti Biosciences Short Squeeze Titan Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GNMX) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings